Nisa Investment Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3M Sell
54,592
-2,472
-4% -$616K 0.05% 230
2025
Q4
$13.7M Sell
57,064
-8,278
-13% -$2.12M 0.05% 222
2025
Q3
$17.9M Sell
65,342
-3,302
-5% -$902K 0.07% 187
2025
Q2
$17.7M Buy
68,644
+4,282
+7% +$1.02M 0.08% 190
2025
Q1
$14.4M Sell
64,362
-843
-1% -$197K 0.07% 214
2024
Q4
$14.9M Sell
65,205
-5,808
-8% -$1.4M 0.06% 231
2024
Q3
$17.3M Buy
71,013
+4,310
+6% +$963K 0.1% 188
2024
Q2
$12.8M Sell
66,703
-10
-0% -$2.03K 0.08% 231
2024
Q1
$13.2M Sell
66,713
-150
-0.2% -$27.5K 0.09% 233
2023
Q4
$11.5M Buy
66,863
+7,594
+13% +$1.17M 0.08% 238
2023
Q3
$8.76M Sell
59,269
-11,195
-16% -$2.02M 0.07% 279
2023
Q2
$15.4M Sell
70,464
-102
-0.1% -$22.7K 0.11% 195
2023
Q1
$15.5M Sell
70,566
-121
-0.2% -$26.3K 0.12% 189
2022
Q4
$14.7M Sell
70,687
-2,837
-4% -$623K 0.12% 207
2022
Q3
$16.1M Sell
73,524
-4,973
-6% -$1.13M 0.14% 161
2022
Q2
$16.5M Buy
78,497
+15,743
+25% +$3.35M 0.14% 150
2022
Q1
$15.2M Sell
62,754
-10,825
-15% -$2.62M 0.11% 188
2021
Q4
$16.8M Sell
73,579
-7,973
-10% -$2.07M 0.13% 175
2021
Q3
$21.5K Sell
81,552
-20,873
-20% -$5.71M 0.13% 149
2021
Q2
$25.3K Sell
102,425
-628
-0.6% -$132K 0.16% 125
2021
Q1
$20K Buy
103,053
+3,501
+4% +$702K 0.13% 154
2020
Q4
$21.2M Buy
99,552
+18,751
+23% +$3.74M 0.14% 166
2020
Q3
$13.9M Sell
80,801
-83
-0.1% -$15.3K 0.11% 190
2020
Q2
$15.5M Sell
80,884
-9,583
-11% -$1.57M 0.14% 153
2020
Q1
$13.3M Sell
90,467
-4,342
-5% -$692K 0.15% 151
2019
Q4
$14.7M Buy
94,809
+5,274
+6% +$760K 0.13% 176
2019
Q3
$12.1M Sell
89,535
-2,112
-2% -$277K 0.11% 201
2019
Q2
$11.2M Sell
91,647
-11,000
-11% -$1.22M 0.11% 201
2019
Q1
$10.7M Buy
102,647
+3,023
+3% +$312K 0.1% 204
2018
Q4
$11.3M Sell
99,624
-900
-0.9% -$96.4K 0.13% 171
2018
Q3
$11.6M Buy
100,524
+10,749
+12% +$1.18M 0.11% 201
2018
Q2
$9.3M Sell
89,775
-4,800
-5% -$486K 0.1% 219
2018
Q1
$9.29M Sell
94,575
-4,800
-5% -$454K 0.1% 211
2017
Q4
$8.42M Sell
99,375
-50
-0.1% -$4.13K 0.09% 231
2017
Q3
$7.65M Buy
99,425
+4,100
+4% +$314K 0.09% 237
2017
Q2
$7.41M Buy
95,325
+800
+0.8% +$57.2K 0.09% 236
2017
Q1
$6.8M Sell
94,525
-490
-0.5% -$33.9K 0.08% 258
2016
Q4
$5.9M Buy
95,015
+17,500
+23% +$1.07M 0.07% 278
2016
Q3
$5.02M Hold
77,515
0.07% 316
2016
Q2
$4.9M Buy
77,515
+75
+0.1% +$4.42K 0.07% 317
2016
Q1
$4.48M Hold
77,440
0.06% 320
2015
Q4
$4.16M Buy
77,440
+4,900
+7% +$276K 0.06% 326
2015
Q3
$3.7M Sell
72,540
-8,600
-11% -$463K 0.06% 349
2015
Q2
$4.57M Buy
81,140
+600
+0.7% +$37.9K 0.06% 311
2015
Q1
$5.78M Buy
80,540
+1,700
+2% +$110K 0.08% 252
2014
Q4
$4.42M Buy
78,840
+1,000
+1% +$52.2K 0.06% 322
2014
Q3
$3.83M Buy
77,840
+3,000
+4% +$153K 0.05% 346
2014
Q2
$3.79M Buy
74,840
+1,100
+1% +$54.5K 0.05% 353
2014
Q1
$3.29M Hold
73,740
0.05% 385
2013
Q4
$3.47M Hold
73,740
0.05% 368
2013
Q3
$3.9M Hold
73,740
0.06% 319
2013
Q2
$3.33M Buy
+73,740
New +$3.5M 0.05% 348

Other funds holding RMD

Nisa Investment Advisors's RMD Position: Q1 2026 in Review

Nisa Investment Advisors reduced its ResMed (RMD) stake by 4.3% in Q1 2026, selling an estimated $616K and leaving 54,592 shares worth $12.3M. The position accounts for 0.05% of the portfolio, ranked #230.

Nisa Investment Advisors first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.2M in Q4 2020. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Nisa Investment Advisors held 54,592 shares of ResMed worth $12.3M as of Q1 2026.
  • Nisa Investment Advisors sold 2,472 ResMed shares in Q1 2026, an estimated $616K.
  • ResMed made up 0.05% of Nisa Investment Advisors's portfolio in Q1 2026, its #230 holding.
  • Nisa Investment Advisors first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Nisa Investment Advisors's ResMed position peaked at $21.2M in Q4 2020.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.